Literature DB >> 31912465

Bariatric Surgery and Inflammatory Bowel Disease: a Role for Microbiota?

Davide Giuseppe Ribaldone1, Rinaldo Pellicano2.   

Abstract

Mesh：

Year:  2020        PMID： 31912465     DOI： 10.1007/s11695-020-04401-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  8 in total

Review 1.  Bariatric surgery in morbidly obese patients with inflammatory bowel disease: A systematic review.

Authors:  Saeed Shoar; Sayed Shahabuddin Hoseini; Mohammad Naderan; Habibollah Mahmoodzadeh; Fung Ying Man; Nasrin Shoar; Motahar Hosseini; Shahram Bagheri-Hariri
Journal:  Surg Obes Relat Dis       Date:  2016-10-25       Impact factor: 4.734

2.  Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease.

Authors:  Jennifer L Seminerio; Ioannis E Koutroubakis; Claudia Ramos-Rivers; Jana G Hashash; Anwar Dudekula; Miguel Regueiro; Leonard Baidoo; Arthur Barrie; Jason Swoger; Marc Schwartz; Katherine Weyant; Michael A Dunn; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

3.  Is Bariatric Surgery Safe and Effective in Patients with Inflammatory Bowel Disease?

Authors:  Nicholas P McKenna; Elizabeth B Habermann; Alaa Sada; Todd A Kellogg; Travis J McKenzie
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

4.  Bariatric Surgery Is a Safe and Effective Option for Patients with Inflammatory Bowel Diseases: A Case Series and Systematic Review of the Literature.

Authors:  Joshua L Hudson; Edward L Barnes; Hans H Herfarth; Kim L Isaacs; Animesh Jain
Journal:  Inflamm Intest Dis       Date:  2019-03-19

Review 5.  What is the role of bariatric surgery in the management of obesity?

Authors:  E Panteliou; A D Miras
Journal:  Climacteric       Date:  2017-01-04       Impact factor: 3.005

6.  Inflammation in gastrointestinal disorders: prevalent socioeconomic factors.

Authors:  Davide Giuseppe Ribaldone; Rinaldo Pellicano; Giovanni Clemente Actis
Journal:  Clin Exp Gastroenterol       Date:  2019-07-19

7.  Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease.

Authors:  Davide Giuseppe Ribaldone; Gian Paolo Caviglia; Amina Abdulle; Rinaldo Pellicano; Maria Chiara Ditto; Mario Morino; Enrico Fusaro; Giorgio Maria Saracco; Elisabetta Bugianesi; Marco Astegiano
Journal:  J Clin Med       Date:  2019-10-09       Impact factor: 4.241

Review 8.  Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.

Authors:  Jan Bilski; Agnieszka Mazur-Bialy; Dagmara Wojcik; Marcin Surmiak; Marcin Magierowski; Zbigniew Sliwowski; Robert Pajdo; Slawomir Kwiecien; Aleksandra Danielak; Agata Ptak-Belowska; Thomas Brzozowski
Journal:  Biomolecules       Date:  2019-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.